These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 16167831)

  • 1. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons.
    Esselen M; Fritz J; Hutter M; Marko D
    Chem Res Toxicol; 2009 Mar; 22(3):554-64. PubMed ID: 19182879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternariol acts as a topoisomerase poison, preferentially affecting the IIalpha isoform.
    Fehr M; Pahlke G; Fritz J; Christensen MO; Boege F; Altemöller M; Podlech J; Marko D
    Mol Nutr Food Res; 2009 Apr; 53(4):441-51. PubMed ID: 18727009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity.
    Poot M; Hiller KH; Heimpel S; Hoehn H
    Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
    Marx G; Zhou H; Graves DE; Osheroff N
    Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Poisons of DNA topoisomerases I and II].
    Charcosset JY; Soues S; Laval F
    Bull Cancer; 1993 Nov; 80(11):923-54. PubMed ID: 8081034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthocyanin-rich extracts suppress the DNA-damaging effects of topoisomerase poisons in human colon cancer cells.
    Esselen M; Fritz J; Hutter M; Teller N; Baechler S; Boettler U; Marczylo TH; Gescher AJ; Marko D
    Mol Nutr Food Res; 2011 May; 55 Suppl 1():S143-53. PubMed ID: 21280204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells.
    Barret JM; Etiévant C; Baudouin C; Skov K; Charvéron M; Hill BT
    Anticancer Res; 2002; 22(1A):187-92. PubMed ID: 12017285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs.
    Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB
    Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
    Barthelmes HU; Niederberger E; Roth T; Schulte K; Tang WC; Boege F; Fiebig HH; Eisenbrand G; Marko D
    Br J Cancer; 2001 Nov; 85(10):1585-91. PubMed ID: 11720449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of DNA topoisomerases by sanguiin H-6, a cytotoxic dimeric ellagitannin from Sanguisorba officinalis.
    Bastow KF; Bori ID; Fukushima Y; Kashiwada Y; Tanaka T; Nonaka G; Nishioka I; Lee KH
    Planta Med; 1993 Jun; 59(3):240-5. PubMed ID: 8391144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic porphyrins and analogues as new DNA topoisomerase I and II inhibitors.
    Shuai L; Wang S; Zhang L; Fu B; Zhou X
    Chem Biodivers; 2009 Jun; 6(6):827-37. PubMed ID: 19551725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interactions between tumor necrosis factor and inhibitors of DNA topoisomerase I and II.
    Baloch Z; Cohen S; Coffman FD
    J Immunol; 1990 Nov; 145(9):2908-13. PubMed ID: 2170526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of catalytic topoisomerase II inhibitors to probe mechanisms of chemical-induced clastogenicity in Chinese hamster V79 cells.
    Snyder RD
    Environ Mol Mutagen; 2000; 35(1):13-21. PubMed ID: 10692223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The substitution pattern of anthocyanidins affects different cellular signaling cascades regulating cell proliferation.
    Marko D; Puppel N; Tjaden Z; Jakobs S; Pahlke G
    Mol Nutr Food Res; 2004 Sep; 48(4):318-25. PubMed ID: 15497183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of morpholinyl doxorubicins, doxorubicin, and actinomycin D on mammalian DNA topoisomerases I and II.
    Wassermann K; Markovits J; Jaxel C; Capranico G; Kohn KW; Pommier Y
    Mol Pharmacol; 1990 Jul; 38(1):38-45. PubMed ID: 2164630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human DNA topoisomerase inhibitors from Potentilla argentea and their cytotoxic effect against MCF-7.
    Tomczyk M; Drozdowska D; Bielawska A; Bielawski K; Gudej J
    Pharmazie; 2008 May; 63(5):389-93. PubMed ID: 18557426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of DNA topoisomerases I and II to replication origins.
    Falaschi A
    Methods Mol Biol; 2009; 582():131-43. PubMed ID: 19763947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.